← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Lumen Bioscience, Inc.
Seattle, WA
$3,522,275
Total funding
2
Grants
Funding over time
peak $1M · FY2018–24$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$3,522,275 · 2
By mechanism
R42$2,925,300 · 1
R41$596,975 · 1
Investigators at Lumen Bioscience, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.$1,000,000
R42 · FY2021 · AI
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.$1,000,000
R42 · FY2023 · AI
Phase II STTR development of an intranasal/oral Spirulina-based PfCSP malaria vaccine.$925,300
R42 · FY2024 · AI
Development of a Spirulina-based oral malaria vaccine$299,904
R41 · FY2018 · AI
Development of a Spirulina-based oral malaria vaccine$297,071
R41 · FY2019 · AI